ZIA BC010816/ImNIH/Intramural NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2011	1
2012	1
2014	1
2016	2
2019	2
2020	4
2022	1
2023	2
2024	1
2025	0

1

Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.

Mansfield AS, Vivien Yin J, Bradbury P, Kwiatkowski DJ, Patel S, Bazhenova LA, Forde P, Lou Y, Dizona P, Villaruz LC, Arnold SM, Khalil M, Kindler HL, Koczywas M, Pacheco J, Rolfo C, Xia B, Mikula E, Chen L, Patel K, Smith KER, Cao L, Shapiro G, Costello BA, Adjei A, Sharon E, Moscow JA, Zamboni W, Hassan R. Mansfield AS, et al. Lung Cancer. 2024 Sep;195:107928. doi: 10.1016/j.lungcan.2024.107928. Epub 2024 Aug 13. Lung Cancer. 2024. PMID: 39197359 Clinical Trial.

2

Chemotherapy and targeted therapies for unresectable malignant mesothelioma.

Kelly RJ, Sharon E, Hassan R. Kelly RJ, et al. Lung Cancer. 2011 Sep;73(3):256-63. doi: 10.1016/j.lungcan.2011.04.014. Epub 2011 May 28. Lung Cancer. 2011. PMID: 21620512 Free PMC article. Review.

3

Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma.

Nair NU, Jiang Q, Wei JS, Misra VA, Morrow B, Kesserwan C, Hermida LC, Lee JS, Mian I, Zhang J, Lebensohn A, Miettinen M, Sengupta M, Khan J, Ruppin E, Hassan R. Nair NU, et al. Cell Rep Med. 2023 Feb 21;4(2):100938. doi: 10.1016/j.xcrm.2023.100938. Epub 2023 Feb 10. Cell Rep Med. 2023. PMID: 36773602 Free PMC article.

4

Orbital metastases from malignant mesothelioma.

Mian I, Padiernos E, Hassan R, Ghafoor A. Mian I, et al. Lancet Oncol. 2020 Feb;21(2):e117. doi: 10.1016/S1470-2045(19)30822-8. Lancet Oncol. 2020. PMID: 32007197 Free PMC article. No abstract available.

5

NAV-003, a bispecific antibody targeting a unique mesothelin epitope and CD3ε with improved cytotoxicity against humoral immunosuppressed tumors.

Grasso L, Jiang Q, Hassan R, Nicolaides NC, Kline JB. Grasso L, et al. Eur J Immunol. 2023 Aug;53(8):e2250309. doi: 10.1002/eji.202250309. Epub 2023 Jun 20. Eur J Immunol. 2023. PMID: 37146241 Free PMC article.

6

Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.

Thomas A, Chen Y, Berman A, Schrump DS, Giaccone G, Pastan I, Venzon DJ, Liewehr DJ, Steinberg SM, Miettinen M, Hassan R, Rajan A. Thomas A, et al. Lung Cancer. 2016 Nov;101:104-110. doi: 10.1016/j.lungcan.2016.09.015. Epub 2016 Sep 28. Lung Cancer. 2016. PMID: 27794397 Free PMC article.

7

Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors.

Tomar S, Zhang J, Khanal M, Hong J, Venugopalan A, Jiang Q, Sengupta M, Miettinen M, Li N, Pastan I, Ho M, Hassan R. Tomar S, et al. Mol Cancer Ther. 2022 Jul 5;21(7):1195-1206. doi: 10.1158/1535-7163.MCT-22-0073. Mol Cancer Ther. 2022. PMID: 35499461 Free PMC article.

8

Population pharmacokinetics and exposure-response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection.

Gupta A, Hussein Z, Hassan R, Wustner J, Maltzman JD, Wallin BA. Gupta A, et al. Cancer Chemother Pharmacol. 2016 Apr;77(4):733-43. doi: 10.1007/s00280-016-2984-z. Epub 2016 Feb 22. Cancer Chemother Pharmacol. 2016. PMID: 26898299 Free PMC article.

9

CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness.

Inaguma S, Lasota J, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Schrump DS, Hassan R, Kasai K, Miettinen M, Ikeda H. Inaguma S, et al. J Pathol. 2020 Feb;250(2):205-216. doi: 10.1002/path.5361. Epub 2019 Dec 3. J Pathol. 2020. PMID: 31639216 Free PMC article.

10

Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma.

Hassan R, Alley E, Kindler H, Antonia S, Jahan T, Honarmand S, Nair N, Whiting CC, Enstrom A, Lemmens E, Tsujikawa T, Kumar S, Choe G, Thomas A, McDougall K, Murphy AL, Jaffee E, Coussens LM, Brockstedt DG. Hassan R, et al. Clin Cancer Res. 2019 Oct 1;25(19):5787-5798. doi: 10.1158/1078-0432.CCR-19-0070. Epub 2019 Jul 1. Clin Cancer Res. 2019. PMID: 31263030 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year